These effects, together with a former report exhibiting that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 aid the notion of concentrating on ACKR3 as a novel strategy to modulate the opioid method, which could open up new therapeutic avenues for opioid-related